Asmaa Refaat Abdelmonem
Asyut, Egypt
NCT Number: NCT03161899
Thalassemia is a blood disorder passed down through families in which the body makes an abnormal form of hemoglobin. There are 2 main types of thalassemia; Alpha & Beta thalassemia. Alpha thalassemia: occurs when a gene or genes related to the alpha globin protein are missing or mutated.
Beta-thalassemia syndromes are a group of hereditary blood disorders characterized by reduced or absent beta globin chain synthesis. Beta-thalassemias can be classified into:
Silent carrier: completely asymptomatic with normal hematological parameters. Beta-thalassaemia minor (beta-thalassaemia trait): usually asymptomatic; diagnosis is made during a work-up for mild anemia.
Beta-thalassaemia intermedia: usually a similar presentation to beta-thalassaemia major; symptoms are usually less pronounced and the course is usually more insidious.
Beta-thalassaemia major : In which there is complete absence of hemoglobin A
Looking for future studies?
Notify Me6 year–14 year
All sexes
Observational
Asyut, Egypt
In Egypt beta thalassemia-major is the most common type with carrier rate of 5.3 to ≥9%and 1000 new cases born with beta-thalassemia major per 1.5 million live births per year.
Children born with thalassemia major are normal at birth, but develop severe hemolytic anemia during the first year of life. Symptoms are those of anemia (lethargy, poor feeding, pallor…etc.) failure to thrive and organomegaly. Later on they develop signs of extra medullary hematopoiesis .
Optimal nutritional status is important for growth, immune function, bone health and pubertal development . Various reports suggest the incidence of poor growth ranges from 25% to 75% depending on thalassemia syndrome and severity of disease. This marked growth deficits raise a red flag for any pediatrician to evaluate nutritional status of thalassemic patients and detect possible nutritional deficiencies and associated factors.
Etiology of delayed growth and malnutrition reported in thalassemic patient is multifactorial including :
The main aim of this study is to assess the nutritional status of thalassemic patient attending Assiut university Children hospital and to determine the factors involved.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 month
prevalence of malnutrition among thalassemic children attending assiut university children hospital
Time frame: 12 month
determination of the most common causes responsible for poor growth seen in thalassemic patients
Time frame: 18 month
decrease morbidity by providing possible strategies for early prevention of the problem of poor growth occurring in patients with thalassemia major
Assiut University
Other
Evaluation of Nutritional Status in Patients With Thalassemia Major in Assiut University Children Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04523376
Anemia, Anemia, Hemolytic
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02307786
Anemia, Anemia, Hemolytic
Chicago, Illinois, United States
View Trial DetailsNCT04009525
Anemia, Anemia, Hemolytic
Nanning, Guangxi, China
View Trial DetailsNCT00749515
Anemia, Anemia, Hemolytic
Boston, Massachusetts, United States
View Trial Details